Navigation Links
BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
Date:6/11/2009

INDIANAPOLIS, June 11 /PRNewswire/ -- BioStorage Technologies, Inc., a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, announced it will participate in the Institute for International Research (IIR) 2nd Annual Biorepositories Conference, September 21 to 23, 2009 in Philadelphia, as the event's platinum sponsor.

Biorepositories 2009 is the only U.S.-based biobanking conference designed specifically for pharmaceutical and biotech companies and will address critical issues affecting the industry. Building upon last year's success, Biorepositories 2009 is expected to attract a wide range of industry professionals from across the country. This year's event will feature expert presentations and open discussions focused on biorepository opportunities, standardization guidance, current challenges for operational strategies, as well as legal and regulatory issues.

"IIR's Biorepositories Conference brings together an important mix of industry and academia thought leaders, operators and service professionals from around the world and provides an excellent forum for discussing how the latest trends and technologies will affect our industry," says F. John Mills, M.D., Ph.D., Chief Executive Officer of BioStorage Technologies and Chairman of the Board.

"Having the commercial biorepositories market leader (BioStorage) on board as our platinum level sponsor, represents a significant investment and reflects the undeniable growth and importance of the biobanking industry," says Courtney Leonard, Biorepositories 2009 Event Director.

In addition to being a platinum sponsor, BioStorage will have a strong presence at the event by participating in conference workshops, panel discussions and various presentations. Delivered by members of the company's leadership team, each presentation will highlight best practices for improving biospecimen storage, dis
'/>"/>

SOURCE BioStorage Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
2. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
3. BioStorage Technologies Serves as Repository for Landmark Study of Coronary Artery Disease
4. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
5. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
6. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
7. BioStorage Technologies Appoints Lori Ball as Vice President
8. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
9. A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
10. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
11. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. ... longer-term toxicology studies for its newly developed Bruton,s ... RA, have been completed. The results of these ... Food and Drug Administration. The feedback received from ... the ongoing first-in-human study. Additional preclinical work is ...
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... Feb. 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), ... biosimilar therapeutics, today announced that it will be presenting ... on March 2 nd at 3pm PST. Patrick Lucy, ... panel discussing the current state of the biosimilar industry ... For more information on CALBIO 2015 ...
(Date:2/27/2015)...  Steep Hill, the industry leader in cannabis testing ... open a full service medical cannabis quality assurance laboratory ... advanced scientific tools and methodology to the state, for ... currently the only laboratory licensed by the New Mexico ... in order to meet the recently adopted regulatory requirements ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2
... Nanotechnology will significantly change virtually every facet of ... opportunity to shape these changes and to ensure that ... and controlled. A new report by former EPA official ... for the next presidential administration and describes the immediate ...
... Calif., July 23 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ... For the second quarter ended June 30, 2008, ... $0.18 per share, compared to a,net loss of $5.2 ... in 2007.,As of June 30, 2008, the company had ...
... to Present Plans for Regaining Compliance - - NASDAQ ... ... Meets All Other NASDAQ Capital Market Initial Listing ... Rule -, TUSTIN, Calif., July 23 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ...
Cached Biology Technology:Nanotech: A regulatory blueprint for the next administration 2Sangamo BioSciences Reports Second Quarter 2008 Financial Results 2Sangamo BioSciences Reports Second Quarter 2008 Financial Results 3Sangamo BioSciences Reports Second Quarter 2008 Financial Results 4Sangamo BioSciences Reports Second Quarter 2008 Financial Results 5Sangamo BioSciences Reports Second Quarter 2008 Financial Results 6Sangamo BioSciences Reports Second Quarter 2008 Financial Results 7Sangamo BioSciences Reports Second Quarter 2008 Financial Results 8Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 2Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 4
(Date:1/22/2015)... ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its shareholders ... Washington,s Department of Licensing, in the United States, awarded ... for driver,s licenses and identification cards to its subsidiary, Valid ... start in January 2015, with enrollment and card production starting ...
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... MADISON, Wis. , Jan. 15, 2015  BellBrook ... for drug discovery, announced the launch of a ... of the company,s Transcreener UDP Assay, a high ... enzymes. The new assay will allow for sensitive ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... National Osteoporosis Foundation, osteoporosis affects more than 2 million ... more have osteopeniaclinically significant low bone density that is ... the University of Missouri-Columbia has found that men engaging ... incidence of osteopeniaa condition resulting in two times the ...
... at the University of Illinois published a discovery that challenged ... which was based on an analysis of ribosomal RNA, ... opened up a new field of study, and established ... To mark the anniversary of this discovery, the university is ...
... of human bones is vastly different than previously believed ... debilitating bone disorders are treated. Researchers from the ... and the BAM Federal Institute of Materials Research and ... stiffness of bone is predominantly due to the presence ...
Cached Biology News:Study shows some athletic men may risk low bone density 2Symposium marks 30th anniversary of discovery of third domain of life 2Symposium marks 30th anniversary of discovery of third domain of life 3Symposium marks 30th anniversary of discovery of third domain of life 4New research on structure of bones raises questions for treatment of osteoporosis 2
... The Fujifilm Life Science FLA-5100 imaging system ... as large as 40 x 46cm at ... microns. This system is especially suitable for ... general array analysis for genomics., Fuji s ...
... and Non-ionic Detergent Removal , ... selective, virtually no cross-reactivity with other proteins ... pellet , Economical new surface technology, ... can often interfere with protein analysis. SurfactAway ...
Physical Form: saline suspension with ethanol Particle Dim: mean particle size 50 μm Matrix: HyperD F. Useful for the removal of detergents from protein samples....
... The Caliper Sciclone ALH 3000 workstation ... diagnostic applications, from Genomic and Proteomic Sample ... Assays. The modular design of the ... options and accessories to perfectly meet the ...
Biology Products: